Best Practices in Over-Time Virtual Patient Engagement

May 11, 2020White Paper

The pharmaceutical industry is energizing its approach to patient engagement, adopting a patient-centric philosophy that prioritizes involving patients in a meaningful way throughout the drug development lifecycle. Both patients and pharmaceutical teams can benefit from over-time, asynchronous communication. We've compiled some of our best practices around these types of meetings to help medical affairs, clinical/R&D, and commercial teams get high-quality insights in a virtual engagement setting.